Oral administration of sustained release morphine sulfate granules in patients with pain and dysphagia associated with cancer

Clinical Drug Investigation

Volumn 14, Issue SUPPL. 1, 1997, Pages 43-52

  Donnadieu, Stéphane ^a   Hernot, Michel ^b   Suard, Laurence ^a  

^a Hopital Laennec   (France)

^b Laboratoires Ethypharm   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MORPHINE SULFATE; OPIATE; SPARKLET; UNCLASSIFIED DRUG;

ADULT; AGED; ANALGESIA; CANCER; CANCER PAIN; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DROWSINESS; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG RELEASE; DYSPHAGIA; FEMALE; GASTROSTOMY; HEADACHE; HUMAN; INTRAGASTRIC DRUG ADMINISTRATION; MALE; MUSCLE SPASM; NIGHTMARE; NOSE FEEDING; NUTRIENT; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PRURITUS; SUSTAINED RELEASE PREPARATION; SWEATING;

EID: 0030780967     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-199700141-00009     Document Type: Conference Paper

References (18)

1. Cherny NI. Opioid analgesics. Comparative features and presenting guidelines. Drugs 1996; 51 (5): 713-37
2. Warlfield CA. Guidelines for routine use of controlled-release oral morphine sulfate tablets. Semin Oncol 1993; 20 (2) Suppl. 1: 36-47
3. Schobelock MJ, Shepard KV, Mosdell KW, et al. Multiple-dose pharmacokinetic evaluation of two formulations of sustained-release morphine sulfate tablets. Curr Ther Res 1995; 56 (10): 1009-21
4. Finn JW, Walsh TD, MacDonald N, et al. Placebo-blinded study of morphine sulfate sustained-release tablets and immediate-release morphine sulfate solution in outpatients with chronic pain due to advanced cancer. J Clin Oncol 1993; 11 (5): 967-72
5. Walsh TD, MacDonald N, Bruera E, et al. A controlled study of sustained-release morphine sulfate tablets in chronic pain from advanced cancer. Am J Oncol 1992; 15 (3): 268-72
6. Deschamps M, Band PR, Hislop TG, et al. The evaluation of analgesic effects in cancer patients as exemplified by a double-blind, crossover study of immediate-release versus controlled-release morphine. J Pain Symptom Manage 1992; 7 (7): 384-92
7. Thirlwell MP, Sloan PA, Maroun JA, et al. Pharmacokinetics and clinical efficacy of oral morphine solution and controlled-release morphine tablets in cancer patients. Cancer 1989; 63: 2275-83
8. Goughnour BR, Arkinstall WW, Stewart JH. Analgesic response to single and multiple doses of controlled-release morphine tablets and morphine oral solution in cancer patients. Cancer 1989; 63: 2294-7
9. Gillette JF, Ferme C, Gehanno P, et al. Double-blind crossover clinical and pharmacokinetic comparison of oral morphine syrup and sustained release morphine sulfate capsules in patients with cancer-related pain. Clin Drug Invest 1997; 14 Suppl. 1: 28-33
10. Boureau F, Saudubray F, d'Arnoux C, et al. A comparative study of controlled-release morphine (CRM) suspension and CRM tablets in chrome cancer pain. J Pain Symptom Manage 1992; 7 (7): 393-9
11. Bruera E, Fainsinger R, Spachynski K, et al. Steady-state pharmacokinetic evaluation of a novel, controlled-release morphine suppository and subcutaneous morphine in cancer pain. J Clin Pharmacol 1995; 35: 666-72
12. Physician's Desk Reference. 50th ed. Montvale, New Jersey: Medical Economics Company, 1996: 4-7
13. Laffont C, Demange C. Sondes d'alimentation et gélules de morphine à libération prolongée. Monit Hosp 1993; Octobre: 59-60
14. Liefhold J, Heun G, Hermann-Hirche E. Applikation von retardiertem Morphinsulfat bei künstlicher Ernährung. Analgetische Versorgung über eine perkutane endoskopische Gastrostomiesonde (PEG-Sonde). Z Allgemeinmed 1996; 72: 707-9
15. Laboratoires UPSA, data on file
16. Jones R, Hale E, Talomsin L, et al. Kapanol™ capsules: pellet formulation provides alternative methods of administration of sustained-release morphine sulfate. Clin Drug Invest 1996; 12 (2): 88-93
17. Bruera E, Fainsinger R, Spachynski K, et al. Clinical efficacy and safety of a novel controlled-release morphine suppository and subcutaneous morphine in cancer pain: a randomised evaluation. J Clin Oncol 1995; 13 (6): 1520-7
18. Ethypharm morphine sulphate SR - summary of product characteristics. Opinion no. 263, CPMP 1993